Influenza News and Research

Latest Influenza News and Research

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

A recent study published in Viruses reviewed the characteristics of neuraminidase with emphasis on the development of NA-based universal influenza vaccines.

12 Jan 2023

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.

11 Jan 2023

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.

11 Jan 2023

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy to reduce the contagious respiratory disease burden during the winter.

10 Jan 2023

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

A new initiative to better understand respiratory viruses has been launched today (10 January 2023) by the Wellcome Sanger Institute.

10 Jan 2023

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

A recent study published in the journal Scientific Reports examined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole genome data to determine the deletion mutations around the spike protein region associated with increased transmission of the virus and identified an increase in the deletion-prone spike protein regions indicating an evolution strategy for immune escape.

9 Jan 2023

Compounds derived from B.C. sea sponge can prevent COVID-19 infection in human cells

UBC researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a B.C. sea sponge.

9 Jan 2023

Researchers study the spatial distribution of SARS-CoV-2 Omicron BA.1 variant in England

Researchers performed a genomic assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant’s BA.1 subvariant transmission in England.

9 Jan 2023

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

Europe is experiencing an increasingly large circulation of influenza and the respiratory syncytial virus (RSV).

9 Jan 2023

What was the prevalence of respiratory syncytial virus between August and December 2022?

Researchers presented the initial respiratory syncytial virus (RSV) surveillance findings for the period between August and December 2022.

9 Jan 2023

New model for detecting and estimating pathogen variant dynamics and risk

A recent study posted to the medRxiv* preprint server developed a hierarchical modeling method to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant fitness advantage and prevalence.

8 Jan 2023

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

A new study aimed to analyze whether the order of immunization of vaccine types impacted the efficacy of a heterologous prime-boost vaccination strategy.

6 Jan 2023

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.

6 Jan 2023

Recently discovered protein holds potential for the development of new tests for infectious diseases

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA.

4 Jan 2023

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

4 Jan 2023

Bacterial outer membrane vesicles: utility as vaccines and novel engineering approaches

Scientists have described the utility of gram-negative bacteria-derived outer membrane vesicles as vaccines and methods to expand their applications.

3 Jan 2023

COVID-19 prevention and control measures associated with decrease in influenza activity

A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact under various prevention and control levels. This study, the first of its kind, was published in Health Data Science, a Science Partner Journal.

2 Jan 2023

Influenza News and Research

Latest Influenza News and Research

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

Compounds derived from B.C. sea sponge can prevent COVID-19 infection in human cells

Researchers study the spatial distribution of SARS-CoV-2 Omicron BA.1 variant in England

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

What was the prevalence of respiratory syncytial virus between August and December 2022?

New model for detecting and estimating pathogen variant dynamics and risk

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Recently discovered protein holds potential for the development of new tests for infectious diseases

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Bacterial outer membrane vesicles: utility as vaccines and novel engineering approaches

COVID-19 prevention and control measures associated with decrease in influenza activity

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Alveolar macrophages present as antigens to promote virus-specific CD8+ T cell expansion

A genome-based comparison of SARS-CoV-2 XBB recombinant and its parental lineage

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Influenza News and Research

Latest Influenza News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in